The Process Development Blog

Faster development despite rising stereochemical complexity! In this webinar, Brendan Roche, PhD reviews engineering strategies which can be applied to key unit operations (e.g. crystallization, isolation etc.) of enantiomers and diastereomers of varying stereochemical complexity.

Speed development without comprising on quality! In this webinar, Hasbullah Daud, PhD discusses PAT, modelling, and cutting-edge analytical techniques to accelerate the development of this pioneering therapeutic modality.

We’re delighted to announce that our founders Mark Barrett and Brian Glennon received the “Pharma Leader” award at the 2022 Pharma Industry Awards during a gala in Dublin this evening. APC also recieved the prostigous "Pharma Company of the Year" award.

APC and VLE are set to give key technical talks at the 2022 AICHE Annual Meeting, Nov 13-18 during the 'Particle Agglomeration and Granulation Processes' and the 'Particle Technology in Product Design and Manufacturing' session.

In the development of Biologics, a lack of proper process understanding and control often leads to an inability to adequately scale a process, product quality drift and costly delays arising from batch failures and concerns of the regulatory authorities which need to be addressed. APC has developed a unique approach designed to mitigate these issues.

Subtle changes in particle size, shape, and distribution can have a major impact on pharmaceutical solubility and stability. Moreover, low bulk densities can cause flow and formulation challenges during processing.

Good crystallization process design, for intermediates or final APIs, can save you months of time during development. However, crystallization of stereoisomers can be particularly challenging.

In this webinar, we share methods to screen and optimize reactions under extreme time constraints using flow chemistry setups integrated with PAT.